A supplemental new drug application for the AIDS medicine, maraviroc (Celsentri/Selzentry), has been withdrawn by its developers pending further studies of the drug’s efficacy as a once-daily treatment. ---Subscribe to MedNous to access this article--- Company News Regulation & Policy
